AbstractRiV is mainly represented by characteristic exosome‐like particles with a diameter of 30 to 70 nm. RiV particle preparations (RiV‐PP) contain identified proteins. In the present paper, the authors started an evaluation of the hypothesis, that RiV‐reactive antibodies, detected in patient sera by an indirect ELISA, may be used for the diagnosis of pathologic cell proliferations. On the basis of the frequency distribution curve of about 500 blood donor sera, cut‐off values for RiV‐reactive IgG and IgM antibodies could be defined. Additionally it was found that 1.6 % of blood donor sera reacted strongly with an RiV‐PP (of calf kidney cells) for IgG antibodies. 29 % of cancer patient sera (n = 48), 17 % of 53 patients with endoprothetics and with lung disorders, 44.3 % of 115 patient sera of a doctor's practice and 28 % of 97 sera of 10 to 11 years old schoolchildren were positive in the anti‐RiV ELISA with IgG antibodies. About half of the selected group of schoolchildren contained different autoantibodies and some of these children displayed already insulin dependent diabetes mellitus (as shown by others). A correlation of our ELISA results with the other autoimmune antibody results was not found. Using RiV‐PP as an antigen complex, isolated from calf kidney cell cultures or from human FL cell cultures and HeLa cell cultures, results with small differences between human and animal RiV origin were obtained. Using the human RiV, the number of positive sera was not significantly lower. Generally, the anti‐RiV ELISA, using RiV‐PP from human cell cultures, detect autoantibodies against RiV‐specific proteins. This assay may detect, but not diagnose pathologic cell proliferation. The possibilities of RiV ELISA for diagnostics of defined autoimmune diseases, as well as further studies and the more meaningful RiV immunoblot are discussed.